Akari Therapeutics Plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Akari Therapeutics Plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • Akari Therapeutics Plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $16M, a 44.5% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $16M -$12.8M -44.5% Dec 31, 2023 8-K 2024-09-06
Q4 2022 $28.9M -$1.46M -4.8% Dec 31, 2022 8-K 2024-09-06
Q4 2021 $30.3M +$4.11M +15.7% Dec 31, 2021 20-F 2023-05-01
Q4 2020 $26.2M +$4.29M +19.6% Dec 31, 2020 20-F 2022-05-16
Q4 2019 $21.9M +$2.99M +15.8% Dec 31, 2019 20-F 2021-04-21
Q4 2018 $18.9M -$1.16M -5.77% Dec 31, 2018 20-F 2020-03-31
Q4 2017 $20.1M +$4.21M +26.5% Dec 31, 2017 20-F 2019-04-23
Q4 2016 $15.9M +$1.34M +9.18% Dec 31, 2016 20-F 2018-07-18
Q4 2015 $14.6M +$12.1M +505% Dec 31, 2015 20-F 2017-03-31
Q4 2014 $2.41M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.